Envisagenics
Developer of a bioinformatics platform designed to accelerate the development of novel therapeutics. The company's platform incorporates advanced artificial intelligence and machine learning algorithm...
Valuation
$150M
Market implied
Share Price
N/A
Total Raised
$40.5M
Last Round
N/A